Fulgent Genetics FLGT
NASDAQ FLGT
$21.69 -0.16 (-0.73%)
At close: Sep 18, 2026 · 4:00 PM EDT

Fulgent Genetics (FLGT) Liabilities from Discontinued Operations (2015)

Fulgent Genetics' (FLGT) quarterly Liabilities from Discontinued Operations came in at $173000.0 in Q4 2015.

Analysis

Fulgent Genetics (FLGT) Liabilities from Discontinued Operations (2015) Analysis & Trends

Fulgent Genetics has disclosed Liabilities from Discontinued Operations across 1 years of filings, most recently posting $173000.0 for Q4 2015.

  • In Q4 2015, Liabilities from Discontinued Operations changed N/A year-over-year to $173000.0; the TTM figure through Dec 2015 stood at $173000.0 (changed N/A YoY), while the FY2015 annual figure was $173000.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations came in at $173000.0 for Q4 2015 at Fulgent Genetics.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of $173000.0 in Q4 2015 to a low of $173000.0 in Q4 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn
10 Fulgent Genetics 596.80 Mn 334.14 Mn 25.68 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 173,000.00